Maghsoud Dariani
Directeur Technique/Scientifique/R&D chez LOBE SCIENCES LTD.
Fortune : 126 283 $ au 30/06/2024
Profil
Maghsoud Dariani is the founder of Atelier Meats Corp.
He currently holds the position of President, Chief Executive Officer & Director at Semorex, Inc. since 2014.
Additionally, he is currently serving as a Director at Mesa Therapeutics, Inc. and as the Chief Science Officer at Lobe Sciences Ltd.
since 2020.
In his former positions, Mr. Dariani worked as the Vice President-Chiral Pharmaceutical Business Unit at Celgene Corp., Head-Science & Technology at MYOS RENS Technology, Inc., President at Focus Pharmaceuticals Ltd., and Chief Science Officer at SOL Global Investments Corp.Mr. Dariani completed his graduate degree at the University of Massachusetts and his undergraduate degree at The City College of New York.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
LOBE SCIENCES LTD
4,91% | 30/06/2023 | 8 418 840 ( 4,91% ) | 126 283 $ | 30/06/2024 |
Postes actifs de Maghsoud Dariani
| Sociétés | Poste | Début |
|---|---|---|
| LOBE SCIENCES LTD. | Directeur Technique/Scientifique/R&D | 21/07/2020 |
| Semorex, Inc. | Directeur Général | - |
| Mesa Therapeutics, Inc. | Directeur/Membre du Conseil | - |
Atelier Meats Corp.
 Atelier Meats Corp. Miscellaneous Commercial ServicesCommercial Services Atelier Meats Corp. is a Canadian biotechnology company founded by Mohit Bhatia and Maghsoud Dariani. The CEOs are Leighton Bocking and Kelsey Ramsden. The private company is focused on developing lab-grown meats that are both healthy and tasty, while also being competitively priced for human consumption. | Fondateur | - |
Anciens postes connus de Maghsoud Dariani
| Sociétés | Poste | Fin |
|---|---|---|
| SOL GLOBAL INVESTMENTS CORP. | Corporate Officer/Principal | - |
Focus Pharmaceuticals Ltd.
 Focus Pharmaceuticals Ltd. Medical DistributorsDistribution Services Focus Pharmaceuticals Ltd. provides pharmaceuticals marketing and licensing services. It manages and markets generic and branded pharmaceutical products of other companies. The company was founded in 2003 and is headquartered in London, the United Kingdom. | President | - |
| CELGENE | Corporate Officer/Principal | - |
| MEDAVAIL HOLDINGS, INC. | Directeur Technique/Scientifique/R&D | - |
Formation de Maghsoud Dariani
| The City College of New York | Undergraduate Degree |
| University of Massachusetts | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| SOL GLOBAL INVESTMENTS CORP. | Commercial Services |
| LOBE SCIENCES LTD. | Process Industries |
| Entreprise privées | 6 |
|---|---|
MYOS RENS Technology, Inc.
 MYOS RENS Technology, Inc. Medical SpecialtiesHealth Technology MYOS RENS Technology, Inc. operates as a nutrition company, develops and markets products that improve muscle health and performance. Its primary product is Fortetropin, a proprietary bioactive composition derived from fertilized egg yolk, intended to increase lean muscle mass, size, and strength. The company was founded on April 11, 2007 and is headquartered in Cedar Knolls, NJ. | Health Technology |
| Semorex, Inc. | |
| Mesa Therapeutics, Inc. | |
Focus Pharmaceuticals Ltd.
Focus Pharmaceuticals Ltd. Medical DistributorsDistribution Services Focus Pharmaceuticals Ltd. provides pharmaceuticals marketing and licensing services. It manages and markets generic and branded pharmaceutical products of other companies. The company was founded in 2003 and is headquartered in London, the United Kingdom. | Distribution Services |
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ. | Health Technology |
Atelier Meats Corp.
Atelier Meats Corp. Miscellaneous Commercial ServicesCommercial Services Atelier Meats Corp. is a Canadian biotechnology company founded by Mohit Bhatia and Maghsoud Dariani. The CEOs are Leighton Bocking and Kelsey Ramsden. The private company is focused on developing lab-grown meats that are both healthy and tasty, while also being competitively priced for human consumption. | Commercial Services |
